Valeant Pharmaceuticals SWOT Analysis
Here is a detailed SWOT analysis of Valeant Pharmaceuticals covering strengths, weaknesses, opportunities and threats.
Valeant Pharmaceuticals Strengths
- It has over 7500 employees in the organization
- It has broad product base with over 900 products
- It has strong product pipeline with many molecules in last stages of development
- Their recent acquisitions have further strengthened their presence in generic market
- Specialization in neurology and dermatology
- Manufacturing sites in Canada, Brazil, Poland and Mexico
Above are the strengths in the SWOT Analysis of Valeant Pharmaceuticals. The strengths of Valeant Pharmaceuticals looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Valeant Pharmaceuticals Weaknesses
- Company has limited presence in emerging markets which has huge potential
- Largely dependent upon America for revenue generation
These were the weaknesses in the Valeant Pharmaceuticals SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Valeant Pharmaceuticals Opportunities
- Opportunity to grow in new markets such as Russia & Brazil through acquisitions
- Strong growth in generics & OTC drugs
- Increasing ageing populations
Above we covered the opportunities in Valeant Pharmaceuticals SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Valeant Pharmaceuticals Threats
- US healthcare reforms
- Economic slowdown reducing spend on healthcare
- Strong competition in branded drugs segments
The threats in the SWOT Analysis of Valeant Pharmaceuticals are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Valeant Pharmaceuticals SWOT analysis.
Read Similar SWOT analysis
About Valeant Pharmaceuticals
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Valeant Pharmaceuticals Overview | |
|---|---|
| Parent Company |
Valeant Pharmaceuticals International |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Multinational specialty pharmaceutical company |
| USP |
It is leading company in neurology & dermatology segments |
| Valeant Pharmaceuticals STP | |
| Segmentation |
Dermatology, neurology & ophthalmic segment |
| Target Market |
Healthcare professionals, patients & hospitals operating in these segments |
| Positioning |
It is diversifies specialty pharmaceutical company |
Browse marketing analysis of more brands and companies similar to Valeant Pharmaceuticals. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
